|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-3-23
|
|
pubmed:abstractText |
Acute hepatitis caused by recurrent or de novo hepatitis B virus (HBV) infection after liver transplantation frequently induces aggressive disease leading to liver failure. The aim of this study was to determine the efficacy and safety of lamivudine treatment in post-transplant acute hepatitis B.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:AndreonePP,
pubmed-author:BelliLL,
pubmed-author:BernardiMM,
pubmed-author:CaraceniPP,
pubmed-author:CavallariAA,
pubmed-author:D'ErricoAA,
pubmed-author:Dal MonteP RPR,
pubmed-author:ErcolaniGG,
pubmed-author:FortiDD,
pubmed-author:GraziG LGL,
pubmed-author:IdeoGG,
pubmed-author:JovineEE,
pubmed-author:MazziottiAA,
pubmed-author:MilandriG LGL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
985-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9875646-Acute Disease,
pubmed-meshheading:9875646-Adult,
pubmed-meshheading:9875646-Antiviral Agents,
pubmed-meshheading:9875646-Female,
pubmed-meshheading:9875646-Hepatitis B,
pubmed-meshheading:9875646-Humans,
pubmed-meshheading:9875646-Lamivudine,
pubmed-meshheading:9875646-Liver Failure,
pubmed-meshheading:9875646-Liver Transplantation,
pubmed-meshheading:9875646-Male,
pubmed-meshheading:9875646-Middle Aged,
pubmed-meshheading:9875646-Recurrence
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Lamivudine treatment for acute hepatitis B after liver transplantation.
|
|
pubmed:affiliation |
Dipartimento di Medicina Interna, Cardioangiologia ed Epatologia, University of Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article
|
